The impact of bevacizumab on temozolomide concentrations in intracranial U87 gliomas

被引：0
|
作者：
Rachel Grossman
Michelle A. Rudek
Harry Brastianos
Patti Zadnik
Henry Brem
Betty Tyler
Jaishri O. Blakeley
机构：
[1] Tel-Aviv Medical Center,Department of Neurosurgery
[2] Johns Hopkins University School of Medicine,The Sidney Kimmel Comprehensive Cancer Center
[3] McMaster University,Department of Medicine
[4] Johns Hopkins University School of Medicine,Department of Neurosurgery
[5] Johns Hopkins University School of Medicine,Department of Neurology, Neurosurgery and Oncology
[6] Johns Hopkins University School of Medicine,Department of Neurosurgery, Oncology and Biomedical Engineering
来源：
Cancer Chemotherapy and Pharmacology | 2012年 / 70卷
关键词：
Microdialysis; Brain tumor; Angiogenesis; Temozolomide; Bevacizumab; U87 glioma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：129 / 139
页数：10
相关论文
共 50 条
  • [21] Effect of β-elemene on human glioma U87 cells
    Du, Xiaofei
    Yang, Jingyu
    Dong, Yingxu
    Wu, Chunfu
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 119 - 119
  • [22] 浅谈Neumann U87麦克风
    莎茹拉
    数字传媒研究, 2024, 41 (02) : 36 - 38
  • [23] Nef increases mitochondrial staining in U87 astrocytes
    Lamboy, R.
    Noel, R.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2017, 12 : S31 - S31
  • [24] Durable response of intracranial cellular hemangioma to bevacizumab and temozolomide
    Yeo, Kee Kiat
    Puscasiu, Elena
    Keating, Robert F.
    Rood, Brian R.
    JOURNAL OF NEUROSURGERY-PEDIATRICS, 2013, 11 (06) : 682 - 686
  • [25] Proline oxidase controls proline, glutamate, and glutamine cellular concentrations in a U87 glioblastoma cell line
    Cappelletti, Pamela
    Tallarita, Elena
    Rabattoni, Valentina
    Campomenosi, Paola
    Sacchi, Silvia
    Pollegioni, Loredano
    PLOS ONE, 2018, 13 (04):
  • [26] Dithiarsolanes in the treatment of glioma: in vitro activity on U87 cell line and brain concentrations on a mouse model
    Ajana, I.
    Astier, A.
    Lanhers, M. C.
    Demore, B.
    Socha, M.
    Gibaud, S.
    EJC SUPPLEMENTS, 2009, 7 (02): : 125 - 125
  • [27] Temozolomide or bevacizumab for spinal cord high-grade gliomas
    Kaley, Thomas J.
    Mondesire-Crump, Ijah
    Gavrilovic, Igor T.
    JOURNAL OF NEURO-ONCOLOGY, 2012, 109 (02) : 385 - 389
  • [28] COMBINED BEVACIZUMAB AND TEMOZOLOMIDE ON PEDIATRIC BRAIN STEM PONTINE GLIOMAS
    Ting-Rong, Hsu
    Muh-Li, Liang
    Kai-Ping, Chang
    Tai-Tong, Wong
    Hsin-Hung, Chen
    NEURO-ONCOLOGY, 2012, 14 : 31 - 31
  • [29] Impact of extremely low-frequency electromagnetic field (100 Hz, 100 G) exposure on human glioblastoma U87 cells during Temozolomide administration
    Ahmadi-Zeidabadi, Meysam
    Akbarnejad, Zeinab
    Esmaeeli, Marzie
    Masoumi-Ardakani, Yaser
    Mohammadipoor-Ghasemabad, Lily
    Eskandary, Hossein
    ELECTROMAGNETIC BIOLOGY AND MEDICINE, 2019, 38 (03) : 198 - 209
  • [30] Temozolomide or bevacizumab for spinal cord high-grade gliomas
    Thomas J. Kaley
    Ijah Mondesire-Crump
    Igor T. Gavrilovic
    Journal of Neuro-Oncology, 2012, 109 : 385 - 389
12345